David Miller, Qi Zhou, S. Banerjee, A. Clamp, P. Qu, Marilyn Huang, N. Nevadunsky, G. Konecny
{"title":"TP035/#1557 Phase 3 study assessing the efficacy of adding AL3818 (catequentinib dihydrochloride, anlotinib hydrochloride) to chemotherapies in subjects with platimum resistant and refractory ovarian carcinoma","authors":"David Miller, Qi Zhou, S. Banerjee, A. Clamp, P. Qu, Marilyn Huang, N. Nevadunsky, G. Konecny","doi":"10.1136/ijgc-2022-igcs.544","DOIUrl":"https://doi.org/10.1136/ijgc-2022-igcs.544","url":null,"abstract":"","PeriodicalId":105919,"journal":{"name":"E-Posters (Trials In Progress)","volume":"52 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"116777048","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
P. Thaker, D. Richardson, W. Bradley, L. Kuroki, Robert Holloway, S. Depasquale, Mark Reed, A. Bregar, J. Scalici, Melanie K. Bergman, Charles Leath Iii, M. Bell, C. Darus, Karen Finkelstein, B. Pothuri, D. Warshal, Nicholas Borys
{"title":"TP022/#1424 A phase I/II study evaluating intraperitoneal GEN-1 in combination with neoadjuvant chemotherapy in patients newly diagnosed with advanced epithelial ovarian cancer","authors":"P. Thaker, D. Richardson, W. Bradley, L. Kuroki, Robert Holloway, S. Depasquale, Mark Reed, A. Bregar, J. Scalici, Melanie K. Bergman, Charles Leath Iii, M. Bell, C. Darus, Karen Finkelstein, B. Pothuri, D. Warshal, Nicholas Borys","doi":"10.1136/ijgc-2022-igcs.531","DOIUrl":"https://doi.org/10.1136/ijgc-2022-igcs.531","url":null,"abstract":"","PeriodicalId":105919,"journal":{"name":"E-Posters (Trials In Progress)","volume":"39 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"122508367","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
I. Vergote, M. Mirza, J. Sehouli, D. Lorusso, F. Köse, D. Cibula, A. Westermann, D. Collins, S. Banerjee, A. Oaknin, I. Soumaoro, Shweta Jain, B. Monk
{"title":"TP004/#1457 Trial in progress of engot-CX8/GOG-3024/innovaTV 205: addition of a new cohort using first-line tisotumab vedotin + pembrolizumab + carboplatin ± bevacizumab in recurrent/metastatic cervical cancer","authors":"I. Vergote, M. Mirza, J. Sehouli, D. Lorusso, F. Köse, D. Cibula, A. Westermann, D. Collins, S. Banerjee, A. Oaknin, I. Soumaoro, Shweta Jain, B. Monk","doi":"10.1136/ijgc-2022-igcs.513","DOIUrl":"https://doi.org/10.1136/ijgc-2022-igcs.513","url":null,"abstract":"","PeriodicalId":105919,"journal":{"name":"E-Posters (Trials In Progress)","volume":"29 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"134079905","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"TP013/#1437 ENGOT-EN19/NSGO-CTU/ALPACA: a randomised phase II trial of alpelisib in combination with letrozole for patients with advanced or recurrent endometrial cancer","authors":"M. Mirza","doi":"10.1136/ijgc-2022-igcs.522","DOIUrl":"https://doi.org/10.1136/ijgc-2022-igcs.522","url":null,"abstract":"","PeriodicalId":105919,"journal":{"name":"E-Posters (Trials In Progress)","volume":"249 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"133853043","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Elizabeth K. Lee, N. Tayob, Bj Rimel, A. W. Hendrickson, A. Nixon, U. Matulonis, Joyce F. Liu
{"title":"TP031/#1443 A phase II trial of pembrolizumab and lenvatinib in recurrent or persistent clear cell carcinoma of the ovary","authors":"Elizabeth K. Lee, N. Tayob, Bj Rimel, A. W. Hendrickson, A. Nixon, U. Matulonis, Joyce F. Liu","doi":"10.1136/ijgc-2022-igcs.540","DOIUrl":"https://doi.org/10.1136/ijgc-2022-igcs.540","url":null,"abstract":"","PeriodicalId":105919,"journal":{"name":"E-Posters (Trials In Progress)","volume":"43 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"126967568","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
V. Salutari, Floriana Camarda, L. Musacchio, S. Scalone, A. Savarese, S. Gori, M. V. Carbone, C. Nero, P. Vici, A. Bergamini, C. Zamagni, G. Scambia, D. Lorusso
{"title":"TP003/#1533 MITO CERV3_phase II study on carboplatin-paclitaxel-pembrolizumab in neoadjuvant treatment of locally advanced cervical cancer","authors":"V. Salutari, Floriana Camarda, L. Musacchio, S. Scalone, A. Savarese, S. Gori, M. V. Carbone, C. Nero, P. Vici, A. Bergamini, C. Zamagni, G. Scambia, D. Lorusso","doi":"10.1136/ijgc-2022-igcs.512","DOIUrl":"https://doi.org/10.1136/ijgc-2022-igcs.512","url":null,"abstract":"","PeriodicalId":105919,"journal":{"name":"E-Posters (Trials In Progress)","volume":"45 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"122199835","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
T. Herzog, J. Hays, K. Moore, P. Konstantinopoulos, L. Gilbert, B. Monk, D. O’Malley, J. Barlin, J. Rege, Monali Desai, Yangchun Du, R. Dalal, R. Coleman, J. Sehouli
{"title":"TP025/#1399 Artistry-7: phase 3 multicenter study of nemvaleukin alfa plus pembrolizumab versus chemotherapy in patients with platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer","authors":"T. Herzog, J. Hays, K. Moore, P. Konstantinopoulos, L. Gilbert, B. Monk, D. O’Malley, J. Barlin, J. Rege, Monali Desai, Yangchun Du, R. Dalal, R. Coleman, J. Sehouli","doi":"10.1136/ijgc-2022-igcs.534","DOIUrl":"https://doi.org/10.1136/ijgc-2022-igcs.534","url":null,"abstract":"","PeriodicalId":105919,"journal":{"name":"E-Posters (Trials In Progress)","volume":"21 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"122301009","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
C. Choi, Byoung-Gie Kim, Jeong-Won Lee, Tae-Joong Kim, Y. Lee, J. Noh, Chi-Son Chang, S. Song, D. Cho, Byoung-Kwan Park, D. Kim, Ki Dong Kim, H. Kim, Jung-Yun Lee, M. Lim, Insu Jeon, Boyeong Song, K. Shin, Wu-Hyun Kim, Chang-Yuil Kang
{"title":"TP002/#1563 An open label, single arm, multicenter trial of durvalumab and BVAC-C, in patients with HPV 16 or 18 positive recurrent cervical cancer","authors":"C. Choi, Byoung-Gie Kim, Jeong-Won Lee, Tae-Joong Kim, Y. Lee, J. Noh, Chi-Son Chang, S. Song, D. Cho, Byoung-Kwan Park, D. Kim, Ki Dong Kim, H. Kim, Jung-Yun Lee, M. Lim, Insu Jeon, Boyeong Song, K. Shin, Wu-Hyun Kim, Chang-Yuil Kang","doi":"10.1136/ijgc-2022-igcs.511","DOIUrl":"https://doi.org/10.1136/ijgc-2022-igcs.511","url":null,"abstract":"","PeriodicalId":105919,"journal":{"name":"E-Posters (Trials In Progress)","volume":"175 4","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"132478669","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
R. Porter, N. Tayob, Madeline Polak, Hannah Sawyer, J. Gardner, S. Campos, C. Krasner, Elizabeth K. Lee, Joyce F. Liu, E. Stover, J. Veneris, A. Wright, U. Matulonis, P. Konstantinopoulos
{"title":"TP015/#1566 A phase 2, two-stage, study of mirvetuximab soravtansine (IMGN853) in combination with pembrolizumab in patients with microsatellite stable (MSS) recurrent or persistent endometrial cancer (EC)","authors":"R. Porter, N. Tayob, Madeline Polak, Hannah Sawyer, J. Gardner, S. Campos, C. Krasner, Elizabeth K. Lee, Joyce F. Liu, E. Stover, J. Veneris, A. Wright, U. Matulonis, P. Konstantinopoulos","doi":"10.1136/ijgc-2022-igcs.524","DOIUrl":"https://doi.org/10.1136/ijgc-2022-igcs.524","url":null,"abstract":"","PeriodicalId":105919,"journal":{"name":"E-Posters (Trials In Progress)","volume":"1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"128508004","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
D. Richardson, J. P. Perez Fidalgo, A. González-Martín, A. Oaknin, E. Hamilton, J. Hays, B. Pothuri, K. Papadopoulos, S. Taylor, Marilyn Huang, Y. Lee, T. Krivak, V. Moreno-García, E. Calvo, L. Randall, D. Starks, Malcom Ross, L. Duska, Bo Gao, R. Póka, E. Putiri, J. Barrett, L. Demars, N. Concin
{"title":"TP036/#426 Uplift (ENGOT-OV67/GOG-3048) a pivotal cohort of the XMT-1536–1 trial of upifitamab rilsodotin (XMT-1536; UPRI), a NAPI2B-directed antibody drug conjugate (ADC) in platinum-resistant ovarian cancer","authors":"D. Richardson, J. P. Perez Fidalgo, A. González-Martín, A. Oaknin, E. Hamilton, J. Hays, B. Pothuri, K. Papadopoulos, S. Taylor, Marilyn Huang, Y. Lee, T. Krivak, V. Moreno-García, E. Calvo, L. Randall, D. Starks, Malcom Ross, L. Duska, Bo Gao, R. Póka, E. Putiri, J. Barrett, L. Demars, N. Concin","doi":"10.1136/ijgc-2022-igcs.545","DOIUrl":"https://doi.org/10.1136/ijgc-2022-igcs.545","url":null,"abstract":"","PeriodicalId":105919,"journal":{"name":"E-Posters (Trials In Progress)","volume":"21 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"129580741","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
